SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-487656
Filing Date
2012-11-30
Accepted
2012-11-30 16:42:03
Documents
4
Period of Report
2012-11-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d446544d8k.htm 8-K 21047
2 ENGLISH TRANSLATION OF PRESS RELEASE d446544dex991.htm EX-99.1 45176
3 GRAPHIC g446544g53o26.jpg GRAPHIC 3104
4 GRAPHIC g446544g59y31.jpg GRAPHIC 4839
  Complete submission text file 0001193125-12-487656.txt   78636
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 121235137
SIC: 2834 Pharmaceutical Preparations